Turn Therapeutics Inc. Common Stock (TTRX) — Net Asset Quality Index
Turn Therapeutics Inc. Common Stock (TTRX) has a Net Asset Quality Index of 32.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $18.64 Million minus total liabilities of $12.53 Million yields net assets of $6.12 Million. A higher index indicates a stronger, lower-leverage balance sheet. See working capital to net assets of Turn Therapeutics Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Turn Therapeutics Inc. Common Stock Net Asset Quality Index Over Time (2023–2025)
This chart shows how Turn Therapeutics Inc. Common Stock's Net Asset Quality Index has evolved across 3 annual periods from 2023 to 2025. As of March 2026, the index stands at 32.8%, representing net assets of $6.12 Million against total assets of $18.64 Million USD. Explore Turn Therapeutics Inc. Common Stock cash conversion from operations to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Turn Therapeutics Inc. Common Stock (2023–2025)
The table below presents the year-by-year Net Asset Quality Index for Turn Therapeutics Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Turn Therapeutics Inc. Common Stock.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 38.5% | $4.69 Million | $12.16 Million | $7.48 Million | ▲ +47.2 pp |
| 2024 | -8.7% | $-177.43K | $2.05 Million | $2.23 Million | ▼ -12.9 pp |
| 2023 | 4.3% | $85.77K | $2.01 Million | $1.93 Million | — |